Investigational Drug Information for D-Proline
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for D-Proline?
D-Proline is an investigational drug.
There have been 4 clinical trials for D-Proline.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2014.
The most common disease conditions in clinical trials are Polycythemia, Polycythemia Vera, and Leukemia, Myeloid. The leading clinical trial sponsors are AOP Orphan Pharmaceuticals AG, PharmaEssentia (Co-Sponsor for USA), and PharmaEssentia Corporation (for the U.S.).
There are two hundred US patents protecting this investigational drug and two international patents.
Summary for D-Proline
US Patents | 200 |
International Patents | 2,852 |
US Patent Applications | 281 |
WIPO Patent Applications | 130 |
Japanese Patent Applications | 0 |
Clinical Trial Progress | Phase 3 (2014-11-01) |
Vendors | 99 |
Recent Clinical Trials for D-Proline
Title | Sponsor | Phase |
---|---|---|
ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission | AOP Orphan Pharmaceuticals AG | Phase 3 |
ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission | Deutsche Krebshilfe e.V., Bonn (Germany) | Phase 3 |
ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission | Philipps University Marburg Medical Center | Phase 3 |
Clinical Trial Summary for D-Proline
Top disease conditions for D-Proline
Top clinical trial sponsors for D-Proline
US Patents for D-Proline
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
D-Proline | See Plans and Pricing | Novel peptidyl carbamate inhibitors of the enzyme elastase | University of Kentucky Research Foundation (Lexington, KY) | See Plans and Pricing |
D-Proline | See Plans and Pricing | Bis(benzylpyrrolidine) derivatives as dopamine agonists | Syntex (U.S.A.) Inc. (Palo Alto, CA) | See Plans and Pricing |
D-Proline | See Plans and Pricing | Bis(benzylpyrrolidine) derivatives useful for treating congestive heart failure and acute renal failure | Syntex (U.S.A.) Inc. (Palo Alto, CA) | See Plans and Pricing |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for D-Proline
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
D-Proline | Australia | AU4511089 | 2008-10-27 | See Plans and Pricing |
D-Proline | Australia | AU629259 | 2008-10-27 | See Plans and Pricing |
D-Proline | Canada | CA2001629 | 2008-10-27 | See Plans and Pricing |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |